LNWTC
WST icon

Laird Norton Wetherby Trust Company’s West Pharmaceutical WST Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Sell
5,078
-53
-1% -$16.2K 0.04% 362
2026
Q1 		$1.29M Buy
5,131
+530
+12% +$132K 0.03% 422
2025
Q4 		$1.27M Buy
+4,601
New +$1.26M 0.03% 443

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Laird Norton Wetherby Trust Company's WST Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its West Pharmaceutical (WST) stake by 1% in Q2 2026, selling an estimated $16.2K and leaving 5,078 shares worth $1.82M. The position accounts for 0.04% of the portfolio, ranked #362.

Laird Norton Wetherby Trust Company first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 5,078 shares of West Pharmaceutical worth $1.82M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 53 West Pharmaceutical shares in Q2 2026, an estimated $16.2K.
  • West Pharmaceutical made up 0.04% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #362 holding.
  • Laird Norton Wetherby Trust Company first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.